Did this Physician Honestly Believe Medicare Would Pay Brand-Name Prices for Generic Products?
The district court denied summary judgment for the defendant, expressing skepticism that a physician could believe that Medicare would allow him to bill for generic therapies at brand-name costs.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.